The document discusses healthcare waste and its management. It states that healthcare waste poses higher risks than other waste due to potential for infections. It also provides definitions of healthcare waste and categories such as infectious, sharp and pharmaceutical waste. The document outlines the major steps in healthcare waste management - segregation, collection, transportation, storage, treatment and disposal. It emphasizes the importance of proper waste handling and treatment to prevent health hazards.
Biomedical waste
‘Bio-medical waste’ means any solid and/or liquid waste including its container and any intermediate product, which is generated during the diagnosis, treatment or immunization of human beings or animals or in research pertaining thereto or in the production or testing thereof.
updated guidelines of hospital infection control, as mentioned in the ppt. its not all the guidelines but yes a brief overview and for further details refer to hospital infection control guidelines pdf.which is available in my uploads.
Biomedical waste
‘Bio-medical waste’ means any solid and/or liquid waste including its container and any intermediate product, which is generated during the diagnosis, treatment or immunization of human beings or animals or in research pertaining thereto or in the production or testing thereof.
updated guidelines of hospital infection control, as mentioned in the ppt. its not all the guidelines but yes a brief overview and for further details refer to hospital infection control guidelines pdf.which is available in my uploads.
India is likely to generate about 775.5 tons of medical wast per day by 2020, from the current level of 550.9 tons per day growing at CAGR about 7%.
Safe and effective management of waste is not only a legal necessity but also a social responsibility.
This ppt has all the necessary information about "Bio-medical waste management". it is useful for student of medical field as well as anyone who is interested in knowing about it.
This is a document that shows how every one should do in health care program and whow you can make your waste to be non infectious.this is essential for all health care
India is likely to generate about 775.5 tons of medical wast per day by 2020, from the current level of 550.9 tons per day growing at CAGR about 7%.
Safe and effective management of waste is not only a legal necessity but also a social responsibility.
This ppt has all the necessary information about "Bio-medical waste management". it is useful for student of medical field as well as anyone who is interested in knowing about it.
This is a document that shows how every one should do in health care program and whow you can make your waste to be non infectious.this is essential for all health care
Gestational age is a key piece of data used by healthcare providers to determine the timing of various screening tests and assessments of the fetus and mother throughout pregnancy. Gestational age may be assessed at any time during pregnancy, and several modes of assessment exist, each requiring different equipment or skills and with varying degrees of accuracy. Obtaining more accurate estimates of gestational age through better diagnostic approaches may initiate more prompt medical management of a pregnant patient.
“Programmed instruction is planned sequence of
experiences, leading to proficiency in terms of stimulus
response relationship”
-James E Espich &Williams
Shock can be best be defined as a complex
life threatening condition characterised by
inadequate blood supply to the tissues and cell
body .
[BRUNNER&SUDDARTH]
Human sexuality is the way people experience & express themselves sexuality. This involves biological, erotic, physical, emotional, social, or spiritual feelings and behaviors. Physical and emotional aspects of sexuality include bonds between individuals that are expressed through profound feelings or physical manifestations of love, trust, and care. Social aspects deal with the effects of human society on one's sexuality, while spirituality concerns an individual's spiritual connection with others. Sexuality also affects and is affected by cultural, political, legal, philosophical, moral, ethical, and religious aspects of life
Sexual health is a state of physical, mental and social well-being in relation to sexuality. It requires a positive and respectful approach to sexuality and sexual relationship. Reproductive health implies that people are able to have a responsible, satisfying and safer sex life and that they have the capability to reproduce and the freedom to decide if, when and how often to do so.
University has invested heavily in modernizing classrooms & halls to take advantages on instructional technology in LCD projectors. LCD is used with a computer to project an image on a screen or a blank wall & provide more instruction flexibility in the types of content that can be used in classroom.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
2. INTRODUCTION
The waste produced in the course of health care
activities carries a higher potential for infection
and injury than any type of waste. Therefore safe
and reliable method for its handling is essential.
Inappropriate methods in handling of health care
waste may have serious public health problems
and significant impact on health.
3. KEY FACTS
Of the total amount of waste generated by health-care activities,
about 85% is general, non-hazardous waste.
The remaining 15% is considered hazardous material that may be
infectious, toxic or radioactive.
Every year an estimated 16 billion injections are administered
worldwide, but not all of the needles and syringes are properly
disposed of afterwards.
Open burning and incineration of health care wastes can, under
some circumstances, result in the emission of dioxins, furans, and
particulate matter.
4. DEFINITION
According to bio-medical waste (management &
handling) rules, 1998 of India, “Biomedical waste is
a waste generated during the diagnosis, treatment
or immunization of human beings or animals or
research activities pertaining to or in production or
testing of biological” .
5. Any waste which is generated during the diagnosis ,
treatment or immunization of human beings or animals
Or
Research activities
Or
In the production or testing of biological
Or
In health camps
Waste generated during the diagnosis, testing, treatment,
research or production of biological products for human or
animals (WHO).
6. Types of waste
Infectious waste: waste contaminated with blood and other
bodily fluids (e.g. from discarded diagnostic samples), cultures
and stocks of infectious agents from laboratory work (e.g. waste
from autopsies and infected animals from laboratories), or
waste from patients with infections (e.g. swabs, bandages and
disposable medical devices);
7. Sharps waste: syringes, needles, disposable scalpels and
blades, etc.;
Chemical waste: for example solvents and reagents used for
laboratory preparations, disinfectants, sterilants and heavy
metals contained in medical devices (e.g. mercury in broken
thermometers) and batteries;
8. Pathological waste: human tissues, organs or fluids, body parts
and contaminated animal carcasses;
Pharmaceutical waste: expired, unused and contaminated drugs
and vaccines;
Cytotoxic waste: waste containing substances with genotoxic
properties (i.e. highly hazardous substances that are, mutagenic,
teratogenic or carcinogenic), such as cytotoxic drugs used in
cancer treatment and their metabolites;
9. Radioactive waste: such as products contaminated by
radionuclides including radioactive diagnostic material or
radiotherapeutic materials;
Non-hazardous or general waste: waste that does not pose
any particular biological, chemical, radioactive or physical
hazard.
10. WASTE CATEGORY EXAMPLE
Pathological waste Human tissue / fluids
Sharps Needles , Scalpels ,
Broken glass
Pharmaceutical waste Expired medicines
Genotoxic waste Cytotoxic drugs
Chemical waste Lab reagents, Dis-
infectants
Wastes with high content
of heavy metals
Batteries , Broken
thermometer
Pressurized containers Gas cylinders, Gas
catridges
Radio active waste Unused liquids from
radiotherapy
Infectious waste Lab cultures, waste from
isolation wards
11. Health care waste
Refers to all waste, biological or non biological that is
discarded and not intended for further use.
Health
care
waste Risk
waste
(10 –
25%)
Non risk
waste
(75 – 90%)
WHO estimates
85% of hospital waste in non hazardous
10% is infectious
5% is non infectious
12. SOURCES OF BIO MEDICAL WASTE
MAJOR SOURCES
•Hospitals
•Labs
•Research centers
•Animal research
•Blood bank
•Nursing homes
•Autopsy centers
MINOR SOURCES
•Clinics
•Home care
•Paramedics
•Funeral services
•Instituitions
15. Health care auxillaries & hospital maintenance personnel
Patients in health care establishments
Visitors to health care establishments
16. Workers in support services allied to health
care establishment such as laundries, waste
handling & transportation
17. HAZARDS OF BIOMEDICAL WASTE
HAZARDS FROM INFECTIOUS WASTE AND SHARPS
Pathogens in infectious waste may enter the human body
by a number of routes.
Through a puncture, abrasion or cut in the skin
Through the mucus membrane
By inhalation
By ingestion
18.
19.
20. HAZARDS FROM CHEMICAL & PHARMACEUTICAL WASTE
Chemicals and pharmaceuticals account for about 3% of waste
from health-care activities.
They may be toxic, genotoxic, corrosive, flammable, reactive or
explosive.
Disinfectants: are particularly important members of this group;
they are used in large quantities and often corrosive.
Open burning of healthcare waste and incineration of plastics and
hazardous materials will generate at least 75 hazardous
chemicals as byproducts like oxides of sulphur & nitrogen, carbon
dioxide, dioxins ,furans etc.
Dioxins & furans are carcinogenic .
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44. Bio medical waste management in India (Management & Handling)
Rules 1998, prescribed by ministry of environment and forests;
Government of India came into force on 28th july 1998. This rule
applies to those who generate, collect, receive, store, dispose, treat
or handle the biomedical waste in any manner. Waste are
differentiated into 10 categories , color code is also assigned.
45.
46.
47.
48.
49. STEPS OF BMW MANAGEMENT
SEGREGATION
COLLECTION
INTRAMURAL TRANSPORTATION
STORAGE (TEMPORARY)
TREATMENT
DISPOSAL
50. It means the separation of the mixed waste specifically at its
point of generation as per the color coding specified under
BMWM RULES 2016.
STEP 1: SEGREGATION
51. CATEGORY TYPE OF BAG/
CONTAINER
TYPE OF WASTE TREATMENT/
DISPOSAL OPTION
52.
53. STEP 2: COLLECTION
Collection is the process of taking away the segregated
BMW from its every point of generation in an HCF to be
transported to the storage area with in the HCF.
54. Time of Collection
Bio-medical waste should be collected on daily basis from each ward
of the hospital at a fixed interval of time. There can be multiple
collections from wards during the day
HCF should ensure collection, transportation, treatment and disposal
of bio-medical waste as per BMWM Rules, 2016 and HCF should also
ensure disposal of human anatomical waste, animal anatomical waste,
soiled waste and biotechnology waste within 48 hours
General waste should not be collected at the same time or in the
same trolley in which bio-medical waste is collected.
55. Collection should be daily for most wastes, with collection timed to
match the pattern of waste generation during the day.
Bio-medical waste collected by the staff, should be provided with
PPEs.
56. PACKAGING
Bio-medical waste bags and sharps containers should be
filled to no more than three quarters full. Once this level is
reached, they should be sealed ready for collection.
Plastic bags should never be stapled but may be tied or
sealed with a plastic tag or tie.
Replacement bags or containers should be available at
each waste-collection location so that full ones can
immediately be replaced.
57. Colour coded waste bags and containers should be
printed with the bio-hazard symbol, labelled with details
such as date, type of waste, waste quantity, senders
name and receivers details as well as bar coded label
to allow them to be tracked till final disposal.
Ensure that Bar coded stickers are pasted on each
bag as per the guidelines
58. LABELING
All the bags/ containers/ bins used for collection and storage of bio-
medical waste, must be labelled with the Symbol of Bio Hazard or
Cytotoxic Hazard as the case may be as per the type of waste in
accordance with the BMWM Rules, 2016. Bio-medical waste bags /
containers are required to be provided with bar code labels in
accordance with CPCB guidelines for “Guidelines for barcode
System for Effective Management of Biomedical Waste”.
60. IN HOUSE TRANSPORTATION OF BIO MEDICAL
WASTE
Transportation Trolleys
In house transportation of Bio Medical Waste from site of waste
generation/ interim storage to central waste collection centre, within
the premises of the hospital must be done in closed trolleys /
containers preferably fitted with wheels for easy maneuverability.
61. ROUTE OF INTRAMURAL TRANSPORTATION OF
BIO-MEDICAL WASTE
Route of transportation preferably be planned in such a way
that:
Transportation does not occur through high risk areas
Supplies and waste are transported through separate routes.
Waste is not transported through areas having high traffic of
patients and visitors
Central Waste collection area can be easy accessed through
this route
Safe transportation of waste is undertaken to avoid spillage and
scattering of waste
63. INTERIM STORAGE
Interim storage of bio medical waste is discouraged in the
wards / different departments of HCF.
If waste is needed to be stored on interim basis in the
departments it must be stored in the dirty utility/sections.
No waste should be stored in patient care area and
procedures areas such as Operation Theatre. All infectious
waste should be immediately removed from such areas.
In absence of dirty utilities/ sections such BMW must be stored
in designated place away from patient and visitor traffic or low
traffic area.
64. CENTRAL WASTE COLLECTION ROOM FOR BIO-
MEDICAL WASTE
The location of central waste collection room must be away
from the public/ visitors access.
The space allocation for this room must be as per the
quantity of waste generated from the hospital.
The planned space must be sufficient so as to store at least
two days generation of waste.
Central waste collection room must be roofed and manned
and should be under lock and key under the responsibility
of designated person
65. The entrance of this centre must be accessible through a
concrete ramp for easy transportation of waste collection
trolleys.
Flooring should be of tiles or any other glazed material with
slope so as to ease the cleaning of the area.
Exhaust fans should be provided in the waste collection room
for ventilation. It is to be ensured by the health care facility
that such central storage room is safety inspected for potential
fire hazard and based on such inspection preventive measure
has to be taken by the health care facility like installation of fire
extinguisher, smoke detector etc
66. There should also be provision for water supply adjacent to
central waste storage area for cleaning and washing of this
station and the containers. The drainage from the storage and
washing area should be routed to the Effluent Treatment Plant.
Sign boards indicating relevant details such as contact person
and the telephone number should be provided.
The entrance of this station must be labelled with “Entry for
Authorized Personal Only” and Logo of Bio Medical Waste
Hazard.
It is to be ensured that no general waste is stored in the central
waste collection area.
67. CENTRAL STORAGE FOR HCF HAVING CAPTIVE
TREATMENT AND DISPOSAL SYSTEM
For the health care facilities which are having captive treatment
facility for treatment and disposal of biomedical waste through
incinerators, autoclaves/microwaves, shredders etc. within its
premises must ensure that waste generated from the HCF is
stored in this central waste collection area till it is transported to
reception area of captive waste treatment facility within the
premises.
69. RECORD KEEPING
Every healthcare facility need to maintain the records w.r.to
category wise bio-medical waste generation and its treatment
disposal on daily basis.
Category wise quantity of waste generated from the facility must
be recorded in Bio Medical Waste Register/logbook being
maintained at central waste collection area under the supervision of
one designated person.
A weighing machine as per the specifications given in CPCB
guidelines for bar code system needs to be kept in central waste
collection centre of the HCF having 30 or more than 30 nos. of
beds for weighing the quantity of Bio Medical Waste.
70. HCFs having less than 30 beds shall maintain records of
receipts printed by the CBWTF.
Records on Annual Report on bio-medical waste
management submitted to SPCB.
Records shall be maintained on training on BMW
Management including both Induction and in service training
records.
Maintain record on Immunization of all the employees.
71. UPDATING OF INFORMATION IN WEBSITE
Contact Address and details of the Healthcare Facility .
No. of beds
Details of :
Authorisation under BMWM Rules, 2016
Consent under Water (Prevention and Control of Pollution)
Act, 1974 and Air (Prevention and Control of Pollution) Act,
1981
Quantity of bio-medical waste generation (in kg/day).
Mode of disposal of bio-medical waste (through CBWTF or
through captive treatment facility).
Name and address of the CBWTF through which waste is
disposed off (as applicable) .
72. In case, HCF is having captive treatment facility,
a) bio-medical waste treated (in kg/day)
b) Details of treatment equipment
c)Total nos. and capacity of each treatment equipment (in kg/day)
d) Operating parameters of the treatment equipment as per
BMWM Rules, 2016
Monthly records of bio-medical waste generation (category
wise)
No. of trainings conducted on Bio-medical Waste
Management in the current year
Stats of immunization of Health Care Workers involved in
handling of BMW